CLARA KRAJNIK: Open Payments
NPI 1316398076 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 26 payments from 12 companies in 2025. Trend: 2023 $441 · 2024 $418 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 4 | $189 |
| Axsome Therapeutics, Inc. | 1 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $108 |
| Abbott Laboratories | 4 | $92 |
| ABBVIE INC. | 4 | $71 |
| Braeburn Inc. | 2 | $44 |
| Astellas Pharma US Inc | 1 | $35 |
| Alkermes, Inc. | 1 | $34 |
| Amgen Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: SUBLOCADE, Auvelity, CAPLYTA, FREESTYLE LIBRE 3, MAVYRET, BRIXADI, Veozah, VIVITROL.
Industry payments across AZ — which companies pay providers there.
